Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares
The ADSs will continue to trade over-the-counter under a new CUSIP. Forward’s ordinary shares will not be affected by the change, the change will have no effect on the total number of ordinary shares in the ADS program, nor will it affect the total market value of our ADS or the market cap of the Company.
The new ADS to ordinary share ratio of 1-for-4000 will be effective on
No fractional ADSs will be issued. Holders who would otherwise receive fractional ADSs will receive a cash payment in lieu of such fractional ADSs. The cash in lieu rate will be set when the depositary sells the ADSs that would otherwise have been issued as fractional ADSs in one or more market trades.
Kindly see additional information at the links to the websites of the Company and its depositary, Bank of New York Mellon below.
Forward Pharma A/S Investor Relations Contact:
Source: Forward Pharma A/S